
Federal Bank reported a net profit of ₹1,056.7 crore for the second quarter, surpassing the CNBC-TV18 poll estimate of ₹991.1 crore. This marks an 11% increase year-on-year. Meanwhile, Cipla announced its Q2 results, with a net profit of ₹1,302.5 crore, exceeding the expected ₹1,250.2 crore. Cipla's revenue for the quarter reached ₹7,051 crore, reflecting a 15.2% year-on-year growth from ₹1,131 crore in the same period of FY24. The company's performance is attributed to strong growth in its India business and a recovery in trade generics sales.
India’s third-largest pharma company Cipla posted a 15.2% Y-o-Y growth in its consolidated profit after tax at Rs 1,303 crore for the second quarter of the current financial year, compared to Rs 1,131 crore during the same period in FY24. #Q2FY25 https://t.co/MqFFd0BgmM
#Q2WithETNOW | Cipla Q2: PAT at ₹1,302.5 cr; revenue at ₹7,051 cr @cipla_global #EarningsWithETNOW #StockMarket https://t.co/z6iExxEZYF
#2QWithCNBCTV18 | #Cipla reports #Q2Results 👇 Net profit at ₹1,303 cr vs CNBC-TV18 poll of ₹1,250.2 cr https://t.co/nnN4V0xWFX


